跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Oxonal 10/5 oxycodone hydrochloride/naloxone hydrochloride 10 mg/5 mg modified release tablet blister - TGA Drug Approval Details
Approvals
/
TGA
/
Oxonal 10/5 oxycodone hydrochloride/naloxone hydrochloride 10 mg/5 mg modified release tablet blister
Approved
STANDARD
Oxonal 10/5 oxycodone hydrochloride/naloxone hydrochloride 10 mg/5 mg modified release tablet blister
AU Pharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
3e06df194d348eb8
Company
AU Pharma Pty Ltd
Type
Standard
Approval Details
Approval Id
3e06df194d348eb8
Product Name
Oxonal 10/5 oxycodone hydrochloride/naloxone hydrochloride 10 mg/5 mg modified release tablet blister
Artg Id
414724
Artg Name
Oxonal 10/5 oxycodone hydrochloride/naloxone hydrochloride 10 mg/5 mg modified release tablet blister
Sponsor
AU Pharma Pty Ltd
Artg Date
2024-04-09
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
3e06df194d348eb8
Type
Standard
Back to TGA Approvals